Thrivent Financial For Lutherans Spring Works Therapeutics, Inc. Transaction History

Thrivent Financial For Lutherans

  • $51.6 Billion
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
SELL
$23.15 - $32.71 $299,028 - $422,515
-12,917 Reduced 50.34%
12,745 $334,000
Q1 2023

May 17, 2023
SELL
$24.97 - $34.05 $970,608 - $1.32 Million
-38,871 Reduced 60.23%
25,662 $661,000
Q4 2022

Feb 08, 2023
BUY
$21.73 - $28.72 $1.4 Million - $1.85 Million
64,533 New
64,533 $1.68 Million

Others Institutions Holding SWTX

# of Institutions
241
Shares Held
70.1M
Call Options Held
144K
Put Options Held
257K
View Full List

About SpringWorks Therapeutics, Inc.

SWTX Quotes by TradingView
  • Ticker SWTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,401,100
  • Market Cap $3.37B
  • Description
  • SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...
More about SWTX
Track This Portfolio

Track Thrivent Financial For Lutherans Portfolio

Follow Thrivent Financial For Lutherans and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Thrivent Financial For Lutherans, based on Form 13F filings with the SEC.

News

Stay updated on Thrivent Financial For Lutherans with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email